TREE NEWS reports: AstraZeneca reported third-quarter core earnings per share of $2.79, beating the $2.62 consensus estimate. The pharmaceutical group’s quarterly result came in above analyst expectations.
AstraZeneca Q3 core EPS $2.79 vs $2.62 expected
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
9m ago
CIG Shanghai to redirect HK$1.769B H-share proceeds to optical module capacity
27m ago
Eoptolink Buys Back 975,700 Shares for 200 Million Yuan in First Repurchase
30m ago
Yuanjie Technology Q1-Q3 2026 Net Profit Up 866.88% to RMB 1.024B
53m ago
ICBC Q1-Q3 2026 Net Profit Rises 5.83% to 285.64B Yuan
1h ago
CNOOC Q3 Net Profit 33.3 Billion Yuan, Up 2.7% YoY
1h ago
SF Holding Deputy GM and Board Secretary Gan Ling Resigns for Personal Reasons